Day-to-day opioid withdrawal symptoms, psychological distress, and opioid craving in patients with chronic pain prescribed opioid therapy.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 23 11 2020
revised: 27 02 2021
accepted: 25 03 2021
pubmed: 7 6 2021
medline: 23 9 2021
entrez: 6 6 2021
Statut: ppublish

Résumé

Research has shown that opioid craving is one of the strongest determinants of opioid misuse in patients with chronic pain. To date, however, little is known on the factors that contribute to opioid craving in these patients. It is possible that patients' physical dependence to opioids, manifested by opioid withdrawal symptoms in between daily opioid doses, contribute to opioid craving. Physical dependence symptoms might also lead to psychological distress, which in turn might contribute to opioid craving. The first objective of this study was to examine the day-to-day association between opioid withdrawal symptoms and opioid craving among patients with chronic pain. We also examined whether negative affect and catastrophic thinking mediated this association. In this longitudinal study, chronic pain patients (n = 79) prescribed short-acting opioids completed daily diaries for 14 consecutive days. Diaries assessed a host of pain, psychological, and opioid-related variables. Day-to-day elevations in opioid withdrawal symptoms were associated with heightened opioid craving (p < .001). Results of a multilevel mediation analysis revealed that this association was mediated by patients' daily levels of negative affect and catastrophizing (p < .001). Our study provides valuable new insights into our understanding of factors that may contribute to prescription opioid craving among patients with chronic pain.

Sections du résumé

BACKGROUND
Research has shown that opioid craving is one of the strongest determinants of opioid misuse in patients with chronic pain. To date, however, little is known on the factors that contribute to opioid craving in these patients. It is possible that patients' physical dependence to opioids, manifested by opioid withdrawal symptoms in between daily opioid doses, contribute to opioid craving. Physical dependence symptoms might also lead to psychological distress, which in turn might contribute to opioid craving. The first objective of this study was to examine the day-to-day association between opioid withdrawal symptoms and opioid craving among patients with chronic pain. We also examined whether negative affect and catastrophic thinking mediated this association.
METHODS
In this longitudinal study, chronic pain patients (n = 79) prescribed short-acting opioids completed daily diaries for 14 consecutive days. Diaries assessed a host of pain, psychological, and opioid-related variables.
RESULTS
Day-to-day elevations in opioid withdrawal symptoms were associated with heightened opioid craving (p < .001). Results of a multilevel mediation analysis revealed that this association was mediated by patients' daily levels of negative affect and catastrophizing (p < .001).
CONCLUSIONS
Our study provides valuable new insights into our understanding of factors that may contribute to prescription opioid craving among patients with chronic pain.

Identifiants

pubmed: 34091157
pii: S0376-8716(21)00282-9
doi: 10.1016/j.drugalcdep.2021.108787
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108787

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alice Bruneau (A)

Division of Experimental Medicine, McGill University, Montreal, Canada.

Leah Frimerman (L)

Division of Experimental Medicine, McGill University, Montreal, Canada.

Maria Verner (M)

Faculty of Dentistry, McGill University, Montreal, Canada.

Amanda Sirois (A)

Faculty of Dentistry, McGill University, Montreal, Canada.

Catherine Fournier (C)

Faculty of Dentistry, McGill University, Montreal, Canada.

Katherine Scott (K)

Faculty of Dentistry, McGill University, Montreal, Canada.

Jordi Perez (J)

Department of Anesthesia, McGill University, Montreal, Canada; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada.

Yoram Shir (Y)

Department of Anesthesia, McGill University, Montreal, Canada; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada.

Marc O Martel (MO)

Division of Experimental Medicine, McGill University, Montreal, Canada; Faculty of Dentistry, McGill University, Montreal, Canada; Department of Anesthesia, McGill University, Montreal, Canada; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada. Electronic address: marc.o.martel@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH